[ad_1]
On the Vilnius City Council website, the Atamis company, on behalf of Celltechna, submitted design proposals for a wholesale building with administrative and research laboratory facilities on Melkio Street. The sole shareholder of Celltechna is VABumelis.
Almost 5,000. square meters Energy class A ++, 4.7 Cerdocyon total area, building from 1 to 4 floors. It is expected to employ 100 people.
“The building is being designed on undeveloped commercial land, in the northern part of Vilnius, next to the Molėtai highway,” read the project proposals.
Visualization of Atamis / V. Bumelis is planning a gene therapy and research center
The document states that the designed building consists of three buildings: A – commercial premises, B – commercial premises / laboratories, C – administrative premises.
“A commercial space is projected in building A. The building includes staff rooms and two commercial rooms, along the entire height of the building. Building B has 4 floors and a basement. Sanitary room blocks are provided on each floor. Commercial premises are provided on the ground floor and laboratories on the remaining floors. The three floors of building C are for administration ”, indicate the project proposals.
Visualization of Atamis / V. Bumelis is planning a gene therapy and research center
On the outskirts of Vilnius, a biotech city
In total, Celltechna from V. Bumelis has acquired a 5.2-hectare parcel near the Vilnius Molėtai highway. Earlier it was announced that the total area of the objects will reach about 24 thousand. square meters meters.
V. Boumelis 15 minutes He said he intends to build three factories here. The first would produce products from microbial cells, the second from mammalian cells, and the third from stem cells and gene therapy products.
But if you build three big factories and work in biotechnology, you cannot live without scientific centers. The science center, if necessary, will develop technologies, optimize and increase them. It will also be a good virological center, “he said.
Photo by Julius Kalinskas / 15min / Vladas Algirdas Bumelis
According to the professor, the project proposals presented are the first stage. The first building will house a gene therapy and research center. A virological center could also appear there.
The first phase is expected to be implemented in three to four years. At the same time, the design work of factories will begin, and the first could appear in 4-7 years.
“It is not necessary to build all three factories at the same time,” he said.
V. Bumelis stated that he is currently negotiating with 4-5 partners on the possibility of investing and has signed a letter of intent with two of them.
“I do not claim to be the main shareholder in this project, but it is interesting and important for me to attract him to my homeland, Lithuania. If we build factories here, the products will be produced there for many years and it will be a big boost for Lithuania ”, he is convinced.
Offers to invest in the state
The professor also suggested that the project be implemented through a public-private partnership (PPP) or include it in the national DNA plan.
“But when you go there (to the DNA plan), you see that everything is there for the public sector and nothing for the private sector. You corsairs do what you want and we make all the money, about 90 percent. for the public. And they do a cost-benefit analysis? “Said the professor.
According to V. Bumelis, for about three years he was looking for an area of land where he could implement such a project. Various locations in the country were considered, but the final decision was determined by the potential of the workforce.
“Then there are two centers: Vilnius or Kaunas. I respect Kaunas, but I am from Vilnius, so I decided to do everything in Vilnius. While driving on the Molėtai highway, I bought land on the other side of the Link Mol Linktų shopping center.” We paid a lot of money. , which we really shouldn’t do, since idiots bury money in the ground, “he said.
[ad_2]
